학술논문

iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases.
Document Type
article
Source
Neuron. 94(2)
Subject
Brain
Microglia
Cells
Cultured
Animals
Humans
Mice
Alzheimer Disease
Disease Models
Animal
Peptide Fragments
Amyloid beta-Protein Precursor
Cytokines
Induced Pluripotent Stem Cells
Amyloid beta-Peptides
3D organoids
AD-GWAS
Alzheimer’s disease
Beta-amyloid
Tau
cell models of disease
induced pluripotent stem cells
microglia
mouse transplantation
neurodegenerative diseases
Cells
Cultured
Disease Models
Animal
Genetics
Neurosciences
Brain Disorders
Acquired Cognitive Impairment
Dementia
Aging
Alzheimer's Disease
Alzheimer's Disease including Alzheimer's Disease Related Dementias
Neurodegenerative
Stem Cell Research
2.1 Biological and endogenous factors
1.1 Normal biological development and functioning
Neurological
Neurology & Neurosurgery
Cognitive Sciences
Psychology
Language
Abstract
Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of Aβ fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease.